GlassScriptPhysician profile
Charles Gerard Petersen
NPI 1285684183
$7,619.82
in general payments reported to CMS, 2019-2025
24 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $127 · 2021: $3,857 · 2022: $32.92 · 2023: $1,798 · 2024: $1,404 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,353 · Food and Beverage: $962 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,353.35 |
| Food and Beverage | $961.58 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $3,817.64 | 2021 | |
| Intuitive Surgical, INC. | $1,511.82 | 2023 | Da Vinci Surgical System, Da Vinci Sp |
| Pulmonx Corporation | $1,271.20 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Glaxosmithkline, LLC. | $160.55 | 2019-2023 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $153.04 | 2019-2023 | Breztri, Fasenra, Tezspire |
| Inspire Medical Systems, INC. | $132.53 | 2024 | Inspire |
| Lilly USA, LLC | $113.40 | 2025 | Zepbound |
| Genentech USA, INC. | $109.43 | 2019-2020 | |
| Mylan Specialty L.P. | $55.57 | 2019-2023 | Yupelri |
| Harmony Biosciences LLC | $39.89 | 2023 | Wakix |
| Boston Scientific Corporation | $39.52 | 2021 | |
| Merck Sharp & Dohme LLC | $27.56 | 2023 | |
| Pfizer INC. | $26.05 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.02 | 2019 | |
| Genzyme Corporation | $20.58 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $17.68 | 2023 | Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Circassia INC. | $17.09 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.62 | 2023 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $15.47 | 2019 | |
| Advanced Respiratory, INC | $13.61 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.83 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.